Beta-glucuronidase activity in prostatic carcinoma and benign prostatic hyperplasia
โ Scribed by Jeffrey P. Pearson; Theresa P. Pretlow; Edwin L. Bradley Jr.; Michael C. McGinnis; Thomas G. Pretlow
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 501 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Prostate cancer is one of the commonest neoplasms in elderly males in developed countries. it is not clear which individuals are at high risk of developing aggressive adenocarcinoma of the prostate. biomarkers are therefore urgently needed to identify such individuals. it had been su
BACKGROUND. Benign prostatic hyperplasia (BPH) is mainly a stromal process, showing an increased ratio of stromal to epithelial elements, a collagen type III downregulation, and a collagen types I and IV upregulation. Little is known about elastin gene expression in BPH tissues due to difficulties r
Genetic alterations within diseased prostate tissue were analysed by genomic DNA fingerprinting using a minisatellite probe (lambda 33.6), a simple repetitive oligonucleotide probe (GTG),, and an additional human multilocus probe (pV47-2). In prostatic adenocarcinoma, somatic mutations were detected
The aim of our study was to determine whether leptin, a hormone implicated in both energy-balance and reproductive function, is involved in the etiology of prostate cancer or benign prostatic hyperplasia (BPH). We compared the serum leptin levels of 43 cases of incident prostate cancer, 41 patients